Characterization of PC2, a mammalian Kex2 homologue, following expression of the cDNA in microinjected Xenopus oocytes  by Shennan, Kathleen I.J. et al.
Volume 284, number 2, 277-280 FEBS 09854 
0 1991 Federation of European Biochemical Societies OOI45793/9I/$3.50 
ADONlSOO14579391OQS64Z 
Characterization of PC2, a mammalian Kex2 homologue, following 
June 1991 
expression of the cDNA in microinjected Xenopus oocytes 
Kathleen I.J. Sherman’, Steven P. Smeekens2, Donald F. SteinePZ and Kevin Dochertyl 
I Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Birruingham B15 2TH. UK and 2 Howard Hughes 
Medical Institute and the Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, VS.4 
Received 24 April 199 1 
A human insulinoma cDNA (PC2) that encodes a protein homologous to the KexZ/subtilisin-like proteinases has recently been described [1990. 
J. Biol. Chem. 265.2997-30001. In order to characterise the associated proteinase activity, mRNA encoding PC2 was synthesised in vitro and micro- 
injected into Xcnopus oocytes. The proteinase activity released into the media from oocytes microinjected with PC2 mRNA was assayed using 
small peptide Ruorogenic substrates. Boc.Gln.Arg.Arg aminomethyl coumarin was hydrolysed in a Ca*+-dependent manner. but substrate analogues 
bearing a single basic aminodcid were not. The substrate specificity, inhibitor profile. and pH optimum of 5.5 were compatible with an involvement 
of PC2 in prohormone processing in mammalian cells. 
PC2; Prohormone processing: Subtilisin; Kex2 
1. INTRODUCTION 
Most polypeptide hormones are synthesised as larger 
precursors, from which the bioactive peptides are 
generated by limited proteolysis [l]. Cleavage usually 
occurs at sites marked by pairs of basic amino acids, 
although peptides can also be generated by cleavage at 
single basic amino acids [2]. An endopeptidase is 
thought to cleave on the COOH-terminal side of the 
pairs of basic amino acids and a carboxypeptidase then 
removes the COOH-terminal basic residues [3]. 
Some progress has been made in identifying the en- 
zymes responsible for the intracellular proteolytic pro- 
cessing of prohormones. The prohormone processing 
carboxypeptidase (carboxypeptidase H) has been clon- 
ed and sequenced [4], and endopeptidase involved in 
the processing of proinsulin [S], proopiomelanocortin 
[6], prosomatostatin [7,8], proenkephalin [9] and pro- 
oxytocin/neurophysin [IO] have been described and at 
least partially characterised. However, the only pro- 
polypeptide processing endopeptidase definitively iden- 
tified and characterised atthe protein and gene level is 
the KEX2 gene product of Saccharornyces cerevisiae 
[ 111. The Kex2 enzyme is a Ca2+ -dependent protease 
with a neutral pH optimum, which cleaves pro-cr factor 
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and pro-killer toxin at Lys-Arg and Arg-Arg sites dur- 
ing the transport of these precursors through the 
cellular secretory pathway [12]. 
Recently, a cDNA (PC2) encoding a mammalian 
homologue of Kex2 was cloned from a human in- 
sulinoma cDNA library [ 131. PC2 encodes a 638 amino 
acid protein which contains an NHz-terminal signal 
peptide and a 282 residue domain that is homologous to 
both Kex2 and related bacterial subtilisins (see [14] for 
review). PC2 and Kex2 [15] also showed similarity to 
the furin gene product, a putative membrane-associated 
protein [16]. This similarity suggests that furin might 
also be 6 candidate propolypeptide processing protease. 
Here we describe the biosynthesis of PC2 in Xenopus 
oocytes microinjected with mRNA encoding PC2, and 
the characterisation of the enzymatic activity associated 
with the expressed protein. 
2. EXPERIMENTAL 
2. I I Animals 
Xenoptts laevis were purchased from Xenopus Ltd., Redhill, Sur- 
rey, UK. 
2.2. Chertricals arld reagmrs 
Boc.Gln.Arg.Arg-MCA. Boc.Gln.Gly.A:g-MCA and Boc.Gly. 
Lys.Arg-MCA wcrc from Peninsula Laboratories, St Helens, 
Mcrseysidc, UK; 7.amino-4-methyl coumarin and protehz inhibitors 
wcrc from Sigma, Poole, Dorset, UK and Ep 475 was 3 gift from Dr 
K. Hanada, Taisho Pharmaceutical Co. Ltd., Qitama, Japan. 
2.3, Generul procedures 
Iii vitro transcription, in vitro translation, Xenopus oocsre 
microinjcctions, and SDS polyacrylamidc gel clcctrophorcsis CUS 
PAGE) were pcrformcd OS pwiously dcrcribcd 1171. 
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2.4. Assay for Bor.Gln. Arg.Arg-MCA hydrolysing activity 
Oocyte medium (20 ~1) was incubated at 37’C for 18 h in a reaction 
(final volume 50 ~1) containing 200 mM MES (pH 5.5), I mM C&12, 
1% (v/v) Triton X-IOO, and 100 PM Boc.Gln.Arg.Arg-MCA. The 
reaction was terminated by addition of 0.9 ml 0.125 M ZnSOa and the 
fluorescence of the samples measured at excitation 385 nm and emis- 
sion 465 nm. A standard curve was prepared using 7-amino-4.methyl- 
coumarin. In order to account for effects of additions and pH on the 
low level of fluorescence measured, results were expressed relative to 
the fluorescence measured in media samples from oocytes micro- 
injected with HzO. 
kd 
3. RESULTS 69b 
In order to characterise the protein and enzymatic ac- 
tivity encoded by PC2, capped mRNA was synthesised 
in an in vitro transcription reaction using SP6 RNA 
polymerase. A comparison of the translation products 
in Xenopus oocytes and in a wheat germ cell-free 
translation system is shown in Fig. 1. In the wheat germ 
system a single radiolabelled protein of Mr 69 000 cor- 
responding to pre(pro)PCt was observed. In the media 
from Xenopus oocytes microinjected with PC2 mRNA, 
2 proteins of Mr 71 000 and 68 000 were observed. 
These proteins were not present in media from oocytes 
microinjected with Hz0 suggesting that they were en- 
coded by the PC2 mRNA. Further studies have shown 
that PC2 is synthesised in the oocytes as a 75 kDa 
membrane-associated protein which undergoes pro- 
teolysis to generate the 71 kDa glycosylated protein. 
This protein is released into the media, where it in turn 
undergoes cleavage to generate the 68 kDa mature pro- 
tein (Shennan, Seal, Smeekens, Steiner and Docherty, 
unpublished results). 
46, 
Fig. 1. Translation of PC2 mRNA. Translation was performed in a 
wheat germ cell-free system (IVT) and in microinjecled Xenoprrs 
oocyles (OOC). For the wheat germ system, Hz0 (track I) or PC2 
mRNA (track 2) was added to a reaction mixture containing 
[“Slmethionine (0.5 mCi/ml) in a final volume of 30 pl. 20~1 aliquots 
were analysed by SDS-PAGE and fluorography. Xenoplrs oocytes 
(IO) were microinjected with 50 nl of Hz0 (track 3) or PC2 mRNA 
(track 4) and incubated for 6 h in modified Barth’s saline. The oocytes 
were then incubated in 30 ~1 of modified Barth’s saline containing I 
mCi/ml [“‘SJmethionine for 18 h at 20°C. The media were removed 
and the volume adjusted to 100 b1 wirh modified Barth’s saline, and 
a S ~1 aliquot analysed by SDS-PAGE. “‘C-labellcd molecular weight 
The proteinase activity present i;l the media at dif- 
ferent time points after microinjection of oocytes with 
PC2 mRNA was assayed using a small fluorogenic pep- 
tide substrate, Boc.Gln.Arg.Arg-MCA. Proteinase ac- 
tivity was detected in the media after 4 h, and this activi- 
ty increased uring a subsequent 20 h incubation of the 
oocytes (Fig. 2). The appearance of proteolytic activity 
in the media paralleled the release of the radiolabelled 
PCZ-encoded peptides (data not shown). No proteolytic 
activity could be detected in media from oocytes 
microinjected with HzO. 
,0(-J ,-______ -_. ___- 
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The proteinase activity released into the media from 
oocytes microinjected with PC2 mRNA was inhibited 
by EDTA and EGTA, by leupeptin, antipain and p- 
hydroxymercuribenzoate (Table I). The active-site- 
directed inhibitor Ala-Lys-Arg-chloromethylketone 
(ALACK) was a potent inhibitor, whereas tosyl-l- 
Lysinechloromethylketone (TLCK) and tosylphenylala- 
ninechloromethylketone (TPCK) did not inhibit sub- 
stantially. The secreted proteinase activity was not in- 
hibited by 1, IO-phcnanthroline, pepstatin A (an aspar- 
tate protease inhibitor), PMSF (a serine protease in- 
hibitor) nor by iodoacetic acid, iodoacetamide, E-64 or 
Ep475 (cysteine proteinase inhibitors), The slight ac- 
tivation by dithiothrcitol and inhibition by P-hydroxy- 
Fig. 2. ‘Tinic course of sccrclion. XeIrolzrs oocytcs wcrc tnicroinjcctcd 
with H10 or PC2 mRNA, and incubated in modified Barth’s saline 
for IS II at 20°C. Groups of 10 oocytcs wcrc then insubatcd in 30 111 
modified Barth’s saline, and, at the indicared times, lhc media wcrc 
rcmovcd and fhc volume adjurtcd to 100 111 with modified Barth’s 
saline. 20 /rl allquors of media were then incubalcd in the standard 
proteinarc assny with 100 l&l Boc.Gln,Ar8.Arg-MCA. 
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Inhibitor 
Table I 
Effect of proteinase inhibitors 
Concentration Inhibition 
(mM) Wo) 
EDTA 
-- 
6 100 
EGTA 6 95 
1 ,IO-phenanthroline I 0 
lodoacetic acid 1 13 
lodoacetamide I 0 
2,2’-Dipyridyl disulphide 1 8 
Dithiothreitol 1 -42 
p_Hydroxymercuribenzoate 1 84 
Leupeptin I 91 
Antipain 1 100 
Ala-Lys-Arg-Chloromethylketone 0.1 81 
Ala-Lys-Arg-Chloromethylketone I 95 
Tosyl-L-Lysine Chloromethylketone 0.1 29 
Tosyl-L-Phenylalanine Chloromethylketone 0.1 7 
PhenylmethylsulphonyI fluoride 0.1 0 
Pepstatin A 0.1 0 
E-64 0.1 0 
EP-475 0.1 6 
Oocytes were microinjected with PC2 mRNA, and 24 h later, 20111 aliquots of media were assayed 
under standard reaction conditions (IOOpM Boc.Gln.Arg.Arg-MCA) with the indicated final con- 
centration of inhibitor. Inhibition was then calculated as a percentage of PC2-associated activity 
in the absence of any addition. The results represent the means of triplicate determinations per- 
formed on at least 3 separate occasions. 
mercuribenzoate may be explained by the presence of a 
cysteine residue (Cyszfz) close to the active site histidine 
(HisZo8 [13]. 
The proteinase was activated by Ca’+ in the milli- 
molar range (Ko.s = 1 mM) (Fig. 3), while the pH op- 
timum for the activity was 5.5 (Fig. 4). An extended pH 
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Fig. 3. Ca’ + depcndencc. Xeno/~s oocytes wcrc microinjcctcd with 
H20 or PC2 mRNA and incubated in modified Barth’s saline for 18 
Ii. 20 ~1 aliquots of media were then assayed for proteinase activity 
under standard conditions with the indicated concentration of Cn”, 
Results arc cxprcsscd as fluorescence obtained with media from 
oocy~cs microinjccted with PC2 mRNA as a pcrccntagc of that ob- 
taincd with mcdin from oocytcs microinjcctcd in parallel with HaO. 
profile demonstrated that there was no activity below 
pH 4.0 nor above pH 7.0 (data not shown). 
The substrate specificity of the proteinase activity 
associated with PC2 was investigated using Boc.Gln. 
Gly.Arg-MCA which contained a single basic amino 
acid and Boc.Gly.Lys.Arg-MCA and Boc.Gln.Arg. 
180 r------ 
PH 
Fig. 4. pH optimum. Xertop~s oocytes were microinjccted with Hz0 
or PC2 mRNA and incubated for I8 h in modified Barth’s saline al 
2O’C. 20b1I aliquots of media were then assayed for protcinase activity 
in a reaction mixture containing 1 mM CaCIz, 1% (v/v) Triton X-100 
and either 200 mM sodium acetate, 200 mM MES, or 200 mM BES 
adjusted to pH 4.0-7.0 with NeOH or HCI. Results are expressed as 
fluorescence obtained with media from oocytcs microinjectcd with 
PC2 mKNA as a pcrccntagc of that obtained with media from oocytes 
microinjcctcd with HlO, and rcprcscnt the mean of triplicate dctcr- 
minations pcrformcd on a~ Icast 3 separate occasions. 
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Table Ii 
Substrate specificity 
Substrate Acticity 
(0.1 mM) (fmol free MCA/h) 
Bac.Gln.Gly.Arg-MCA 0 
Boc.Gln.Arg.Arg-MCA 48 
Boc.Gly.Lys.Arg-MCA 150 
_ _._. 
Oocytc were microinjected with PC2 mRNA and 24 h later, 20 ~1 ali- 
quots of media were assayed under standard conditions with either 
100 gM Boc.Gln.Gly.Arg-MCA, 100 PM Boc.Gln.Arg.Arg-MCA or 
100 PM Boc.Gly.Lys.Arg-MCA. 
Arg-containing substrates) is more similar to that of the 
type II enzyme than the type I enzyme. Establishment 
of the relationship between PC2 and the type I and type 
II enzymes must therefore await definitive characterisa- 
tion of the PC2 enzymatic activity using proinsulin as 
substrate. In the present study we were unable to obtain 
such data because of the low level of PC2 activity ex- 
pressed by the oocytes. 
Arg-MCA which contained paired basic amino acids at 
the cleavage site. No activity could be detected with 
Boc.Gln.Gly.Arg-MCA while the activity against 
Boc.Gly.Lys.Arg-MCA was 3 times that detected with 
Boc.Gln.Arg.Arg-MCA (Table II). 
In summary, we have presented data on the expres- 
sion of PC2 in Xenopus oocytes which strongly suggest 
that PC2 is a mammalian prohormone processing pep- 
tidase. Further high efficiency expression studies are re- 
quired to characterise the cleavage specificity against 
various prohormone substrates. 
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